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a b s t r a c t 
Megakaryoblastic leukemia 1 (MKL1) is a member of the MKL family of serum response factor (SRF)
coactivators. Here we have identiﬁed three rat MKL1 transcripts: two are homologues of mouse MKL1
transcripts, full-length MKL1 (FLMKL1) and basic, SAP, and coiled-coil domains (BSAC), the third is a
novel transcript, M KL1- elo ngated d erivative of y ield (MELODY). These rat MKL1 transcripts are differ-
entially expressed in a wide variety of tissues with highest levels in testis and brain. During brain de-
velopment, these transcripts display differential patterns of expression. The FLMKL1 transcript encodes
two isoforms that utilize distinct translation start sites. The longer form possesses three actin-binding
RPXXXEL (RPEL) motifs and the shorter form, MKL1met only has two RPEL motifs. All four rat MKL1
isoforms, FLMKL1, BSAC, MKL1met and MELODY increased SRF-mediated transcription, but not CREB-
mediated transcription. Accordingly, the differential expression of MKL1 isoforms may help ﬁne-tune
gene expression during brain development. 
C © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical
Societies. Open access under CC BY-NC-ND license. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1. Introduction 
The megakaryoblastic leukemia (MKL) family members, MKL1 and
MKL2, function as serum response factor (SRF) coactivators [ 1 –5 ]. Sev-
eral studies conducted in non-neuronal cells have shown that MKL1
binds to G-actin via its RPXXXEL (RPEL) motifs and translocates into
the nucleus where it binds to and activates SRF in response to actin
polymerization and G-actin depletion [ 6 –8 ]. MKL1 and MKL2 regu-
late a set of genes that code for cytoskeletal proteins and are involved
in alteration of cell shape and motility [ 5 ]. MKL family members are
also highly expressed in the brain and they regulate morphology ofAbbreviations: BSAC, basic, SAP, and coiled-coil domains; DAPI, 4 ′ , 6-diamidino-2- 
phenylindole; GFP, green ﬂuorescent protein; MAL, megakaryocytic acute leukemia; 
MKL1, megakaryoblastic leukemia 1; MELODY, MKL1-elongated derivative of yield; 
RPEL, arginine proline XXX glutamate leucine; SRF, serum response factor. 
1 These authors equally contributed to this work. 
* Corresponding author. Tel.: + 81 76 434 7536; fax: + 81 76 434 5048. 
E-mail address: atabuchi@pha.u-toyama.ac.jp (A. Tabuchi). 
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http://dx.doi.org/10.1016/j.fob.2013.09.001 cultured cortical or hippocampal neurons [ 9 –12 ]. 
MKL1 isoforms were initially identiﬁed in non-neuronal cells. One
of the mouse MKL1 cDNAs derived from NIH3T3 cells has two alter-
native translation start sites; the upstream site uses leucine as the
initiator codon and generates full-length MAL / MKL1, MAL / MKL1(ﬂ),
while the downstream site employs methionine as the start codon to
produce a shorter protein, MAL / MKL1(met) [ 6 ]. Another MAL / MKL1
transcript, called BSAC (basic, SAP and coiled-coil domain) has been
identiﬁed in mouse spleen which contains a 5 ′ -exon different from
that of the MAL / MKL1(ﬂ) transcript [ 2 ]. Mouse MAL / MKL1 (ﬂ) and
MAL / MKL1met are able to translocate from the cytoplasm to the nu-
cleus in response to serum-stimulation in NIH3T3 cells [ 6 ]. As MKL1 is
expressed prominently in brain and plays a key role in regulating neu-
ronal morphology, we sought to deﬁne the pattern of expression of
MKL1 transcripts during brain development and whether MKL1 iso-
forms differ in their ability to regulate SRF-mediated transcription.
In the course of these studies, we have identiﬁed a novel MKL1 tran-
script termed M KL1- elo ngated d erivative of y ield (MELODY) and two
MKL1 transcripts which have homology to mouse MAL / MKL1(ﬂ) and
BSAC. Furthermore, we have found that: (1) these MKL1 isoforms are
differentially expressed during brain development, and (2) MELODY,
in addition to FLMKL1, BSAC and MKL1met, activates SRF-mediatedan Biochemical Societies. Open access under CC BY-NC-ND license.
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. Materials and methods 
.1. Animals 
Male SD rats for measuring MKL1 mRNA expression were pur- 
hased from Sankyo Labo Service Corporation, Inc. (Tokyo, Japan). 
ll experiments were carried out in accordance with the guidelines 
f the Animal Care and Experimentation Committee of University of 
oyama, Sugitani Campus. The protocols were approved as permit 
umbers (S-2008 PHA-3, S2009 PHA-23, S2010 PHA-1, A2011 PHA-5, 
2012 PHA-1). Every effort was made to minimize suffering. 
.2. Cloning of rat MKL1 transcripts 
To clone cDNA of rat MKL1 transcripts, the following primers 
or 5 ′ -rapid ampliﬁcation cDNA-end (5 ′ -RACE) were initially de- 
igned based on the predicted rat MKL1 mRNA sequence (NCBI 
eference Sequence: XM 235497.4 ), which was derived by se- 
uence tagged sites (STS) and expressed sequence tags (EST). 
he primers correspond to the predicted exons 7 and 8: RT 
5 ′ -TCTCATTGAGGTC-3 ′ ), sense1 (5 ′ -GAGCCTTCTCTCCAGGCCAA- 
 
′ ), antisense1 (5 ′ -AGGTCTCTTCCAGAATGTGC-3 ′ ), sense2 
5 ′ -GCTGAAGCTGAAGAGAGCCA-3 ′ ), antisense2 (5 ′ - 
CTGACCAGCTCTGATCTCT-3 ′ ). The 5 ′ -RACE procedure was per- 
ormed by PCR with Pfu DNA polymerase (Promega, Madison, WI, 
SA), followed by reverse transcription, degradation of RNA, and 
ircularization with 5 ′ -Full RACE Core Set (TaKaRa, Shiga, Japan) 
n the reaction mixture containing SD rat adult hippocampal RNA. 
equence analysis of the 5 ′ -RACE products revealed that two 
ifferent 5 ′ -ends were present that are homologous to mouse 
ull length MKL1 and BSAC, respectively. These two fragments 
ere tentatively termed full-length MKL1 (FLMKL1) and basic, 
AP and coiled-coil domain (BSAC), respectively. The predicted 
st and 2nd exons were absent in FLMKL1. Thus, the 5 ′ -RACE 
as further performed with AmpliTaq Gold (Applied Biosystems, 
arlsbad, CA, USA), 5 ′ -Full RACE Core Set and primers (RT2: 
 
′ -CCGCTCACTAAGTG-3 ′ ; sense3: 5 ′ -GAACTGCAGGAGCTGTCCCT- 
 
′ ; antisense3: 5 ′ -TTGGCAACAGCTTCGCTCTG-3 ′ ; 
ense4: 5 ′ -TGACTCTGGGCCTCCATCCT-3 ′ ; antisense4: 5 ′ - 
AGAGACAGGAGCACCGGTT-3 ′ ) corresponding to the predicted 
xon 3. The 5 ′ -RACE product possesses a newly identiﬁed 5 ′ -exon 
nd was tentatively named M KL1- elo ngated d erivative of y ield 
MELODY). To obtain FLMKL1, BSAC and MELODY cDNA including 
heir coding regions, PCR was carried out with rat 7-week hippocam- 
al cDNA as a template, PrimeSTAR Max DNA polymerase (TaKaRa), 
ense primers (5 ′ -CGGTACCCGGGGATCCTCGCTAGCCACGCTCCCTC-3 ′ 
or FLMKL1; 5 ′ -CGGTACCCGGGGATCGCTGGGCTTCCTGTCTGCAC-3 ′ 
or BSAC; 5 ′ -CGGTACCCGGGGATCGCAGAGACACCTGTCAGGAC- 
 
′ for MELODY) and antisense primer (5 ′ - 
GACTCTAGAGGATCGCCTCTAGGGACTGTGATTGTC-3 ′ for a common 
 
′ -untranslated region). The sequence analyses of FLMKL1 (DDBJ Ac- 
ession No. AB588919 ), BSAC ( AB588920 ) and MELODY ( AB588921 ) 
ere deposited. 
.3. Search of transcription factor-binding sites within rat MKL1 
enome 
To ﬁnd transcription factor-binding sites upstream of transcription 
tart site of rat MKL1 isoforms, we used the TF search program ( http: / 
 mbs.cbrc.jp / research / db / TFSEARCH.html ), which is directly owned 
o the TRANSFAC databases developed at GBF-Braunschweig, Ger- 
any [ 13 ]. Rat MKL1 genome sequences, shown in the website of En- 
embl database ( http: // www.ensembl.org / index.html ), was used for TF search program. One kilobase long upstream of 5 ′ -ends of FLMKL1, 
MELODY, BSAC were searched at threshold score = 95.0. 
2.4. RNA isolation and real-time quantitative PCR 
Total RNA was extracted from rat tissues and brain regions 
using TRIsure (Bioline). Then, RNA was treated with DNase I and 
further puriﬁed using TRIsure again. Using the RNA solution, 
cDNA was synthesized with SuperScriptII reverse transcriptase 
(Invitrogen, Carlsbad, CA, USA). In brief, for detection of FLMKL1, 
BSAC, and MELODY mRNA levels, the PCR was performed in 
20 μL of 1 × SYBR system using SYBR Green PCR master mix 
(Applied Biosystems, Foster City, CA, USA) containing 2 μL of cDNA 
solution and 0.4 μM primers (5 ′ -TCCTTGAGGCTCGGGAGGATA- 
3 ′ and 5 ′ -GTCCAGCCCATTCACAGCAATG-3 ′ for FLMKL1; 5 ′ - 
GCTTCCTGTCTGCACTCACTC-3 ′ and 5 ′ -GACGGAGTCCTCACGGAAAC- 
3 ′ for BSAC; 5 ′ -CAGAGACACCTGTCAGGACG-3 ′ and 5 ′ - 
GTCCAGCCCATTCACAGCAATG-3 ′ for MELODY). After preheating 
at 95 ◦C for 10 min, the samples were denatured at 95 ◦C for 45 s, 
annealed at 60 ◦C for 45 s, and extended at 72 ◦C for 1 min for 
45 cycles. Quantiﬁcation of each transcript was calculated by the 
following procedure. In brief, the initial cDNA copy number [DNA 0 ], 
which reﬂects mRNA expression of the sample, was calculated 
from PCR-ampliﬁed cDNA copy number [DNA], Ct value ( c ), am- 
pliﬁcation efﬁciency ( e ) and cDNA standard curve. The formula, 
[DNA] = [DNA 0 ](1 + e ) c , was used for calculation. 
2.5. Plasmids and antibodies 
To generate a series of FLAG-tagged rat MKL1 constructs 
(FLAG-FLMKL1, FLAG-BSAC, FLAG-MELODY and FLAG-MKL1met), 
the coding regions of FLMKL1 (from 5 ′ -CCCCCTTCCGTCATT-3 ′ to 
5 ′ -TGGGATTCCTGCTTG-3 ′ ), BSAC (from 5 ′ -ACTCTGCTGGAGCCT-3 ′ to 
5 ′ -TGGGATTCCTGCTTG-3 ′ ), MELODY (from 5 ′ -GGAGGGGTTACCATC- 
3 ′ to 5 ′ -TGGGATTCCTGCTTG-3 ′ ) and MKL1met (from 5 ′ - 
CCGCCTTTGAAAAGT-3 ′ to 5 ′ -TGGGATTCCTGCTTG-3 ′ ) were linked 
to the downstream (5 ′ -CTTGCGGCCGCGAATTCA-3 ′ ) of the FLAG tag 
sequence of pFLAG-CMV2 vector (SIGMA, St. Louis, MO, USA). The 
expression vector for enhanced green ﬂuorescent protein (pEGFP-C1) 
was purchased from Clontech. The SRF reporter vector, 3D.ALuc, 
generously provided by Dr. R. Treisman (Cancer Research Institute, 
London, UK) has been described previously [ 6 , 9 , 11 ]. The CRE-reporter 
vector, pCRE-Luc (CRE-Luc), and the SRE-reporter vector, pSRE-Luc 
(SRE-Luc), were purchased from Stratagene (La Jolla, CA, USA). 
An internal control vector, TK- Renilla vector, has been described 
previously [ 9 ]. The following antibodies were used: anti-green 
ﬂuorescent protein (GFP) made in rabbit (Invitrogen or Medical & 
Biological Laboratories; 1:500 or 1:1000), anti-FLAG (SIGMA; 1:1000) 
made in mouse, and anti- α-tubulin (SIGMA; 1:1000) made in mouse. 
2.6. Cell culture 
NIH3T3 cells were cultured in Dulbecco’s modiﬁed Eagle medium 
(DMEM; Invitrogen) containing 10% fetal bovine serum (Invitrogen), 
10% Nu-serum (BD Biosciences, San Jose, CA, USA), 2 mM glutamine 
(Invitrogen), 1% penicillin / streptomycin (Invitrogen), as described 
previously [ 9 ]. For reporter assays, cells were seeded at 5 × 10 5 cells / 
well and grown on six-well plates (Nalge Nunc, Naperville, IL, USA). 
2.7. Transfection into NIH3T3 cells 
Transfection into NIH3T3 cells was performed using lipofectamine 
(Invitrogen) and Plus reagent (Invitrogen) as described previously [ 9 ]. 
Medium exchange was carried out 4 h after transfection. Cell lysates 
were prepared 20 h after transfection. 
Mitsuru Ishikawa et al. / FEBS Open Bio 3 (2013) 387–393 389 
Fig. 1. Deduced exon–intron organization and domain structure of rat MKL1 isoforms. (A) Deduced exon–intron organization. Boxes indicate exons. Sizes of exons and introns 
are depicted approximately to scale. The predicted exon locations (on the top) are illustrated in accordance with the NCBI’s information (NCBI Reference Sequence: XM 235497.4 
and NW 047780.1 ). The exon (open boxes)–intron organization (the second from the top) is illustrated based on the sequence data shown in this study. The last three structures 
indicate the deduced exon–intron organization of FLMKL1, BSAC and MELODY variants, respectively. Shaded regions indicate the open reading frames. Boxes drawn by broken 
lines indicate the predicted 3 ′ -untranslated regions, which were not analyzed in this study. Thick arrows indicate the putative initiation codons. Thin arrows indicate the location 
of primers used for real-time quantitative PCR measurements of each mRNA transcript. The FLMKL1 possesses two putative initiation codons, possibly giving rise to two different 
proteins, FLMKL1 and MKL1met, respectively (also shown in Fig. 1B). (B) Conserved motifs of FLMKL1, MKL1met, BSAC and MELODY. The illustrated domains were predicted on the 
basis of Pfam ( http: // www.sanger.ac.uk / ). FLMKL1 and MKL1met can be produced by the distinct usage of two initiation codons, CTG and ATG, in a common transcript, respectively 
(see (A)). RPEL: arginine proline XXX glutamate leucine; B1 and B2: basic regions 1 and 2; PolyQ: polyglutamine repeat; SAP: SAF-A / B, Acinus and PIAS; LZ: leucine zipper; TAD: 
transcriptional activation domain. (C) Variation of the N-termini of FLMKL1, MKL1met, BSAC and MELODY. The numbers at both ends indicate the amino acid position of each 
isoform. The rectangle indicates the ﬁrst RPEL motif. The ﬁrst amino acids of the RPEL motif are written in white. 
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Fig. 2. Regional expression of rat MKL1 transcripts in adult tissues. Complementary 
DNA derived from several tissues of 7-week old rat (pancreas, muscle, lung, intestinum, 
spleen, heart, testis, kidney, liver, total brain, olfactory bulb, cerebellum, hippocampus 
and cerebral cortex) was subjected to real-time quantitative PCR analysis with FLMKL1 
(A), BSAC (B), MELODY (C) speciﬁc primers. Primer positions are illustrated in Fig. 1 A. 
Data represent the means ± SD from at least three independent experiments. 
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A.8. Western blotting 
In order to measure the expression levels of FLAG-tagged rat MKL1 
ariants, we performed Western blotting for the FLAG tag ( Fig. 4 A). 
rotein was extracted in the whole cell extract buffer containing 
5 mM HEPES, 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.1% Triton 
-100, 20 mM β-glycerophosphate, 10 μg / mL aprotinin, 10 μg / mL le- 
peptin, 1 mM sodium orthovanadate, 1 mM dithiothreitol, and 1 mM 
henylmethylsulfonyl ﬂuoride. After centrifugation, the cell lysates 
ere mixed with an equal volume of 2 × Laemmli sample buffer 
Bio-Rad Laboratories, Hercules, CA, USA) and subjected to sodium 
odecyl sulfate–polyacrylamide gel electrophoresis. Protein detec- 
ion was carried out with the enhanced chemiluminescence (ECL) 
rotocol (GE Healthcare, Little Chalfont, UK). 
.9. Reporter assay 
Transcriptional activity was monitored using either the ﬁreﬂy lu- 
iferase or Renilla luciferase activity as described previously [ 9 ]. Lu- 
iferase activity was monitored using dual luciferase assays according 
o the manufacturer’s instructions (Promega). 
.10. Statistical analysis 
Statistical signiﬁcance of treatment effects was analyzed by 
NOVA. 3. Results 
3.1. Identiﬁcation of rat MKL1 transcripts 
To identify rat MKL1 transcripts, we ﬁrst designed primers for 5 ′ - 
rapid ampliﬁcation cDNA-end (5 ′ -RACE) based on the predicted rat 
MKL1 mRNA sequence (NCBI Reference Sequence: XM 235497.4 ) ( Fig. 
1 A, on the top). Sequence analysis of the 5 ′ -RACE products generated 
from primers located in predicted exons 7 and 8 revealed that two 
different 5 ′ -ends were present that were homologous to mouse full 
length MAL / MKL1 and BSAC. However, since the predicted exons 1 
and 2, which were provided by NCBI reference sequence, were ab- 
sent from the presumed 5 ′ fragment of rat FLMKL1, we performed 
another round of 5 ′ -RACE with primers corresponding to the pre- 
dicted exon 3. Although these 5 ′ -RACE products still did not contain 
sequences corresponding to either of the predicted exons 1 and 2, 
which were provided by NCBI reference sequence, they did contain a 
transcript with a novel 5 ′ exon that we refer to as MELODY ( M KL1- 
elo ngated d erivative of y ield). Subsequent cloning and sequence anal- 
ysis of the entire FLMKL1 (DDBJ: AB588919 ), BSAC (DDBJ: AB588920 ) 
and MELODY (DDBJ: AB588921 ) cDNAs revealed that the predicted 
1st and 2nd exons were absent from all three rat MKL1 cDNA ob- 
tained in this study ( Fig. 1 A). Each of the three rat MKL1 transcripts 
identiﬁed have distinct 5 ′ -exons, implying that alternative promoters 
may be located upstream of each of these 5 ′ -exons. To ﬁnd transcrip- 
tion factor-binding sites of rat MKL1 gene, we used TF search [ 13 ]. 
Binding sites of ETS, AML-1a are located within 1 kbp upstream of 5 ′ 
ends of FLMKL1. Binding sites of SRY, CdxA, Nkx-2 are located within 
1 kbp upstream of 5 ′ ends of MELODY. SRY, CdxA are located within 
1 kbp upstream of 5 ′ ends of BSAC cDNA. These binding sites may be 
involved in differential regulation of MKL1 isoform transcription. 
The study by Miralles et al. demonstrated that mouse FLMKL1 con- 
tains two alternative translation start sites [ 6 ]. The two translation 
products generated, FLMKL1 and MKL1met, possess three and two 
RPEL motifs, respectively ( Fig. 1 B, on the top and the second rows). Al- 
though the junction between the distinct 5 ′ exon located in BSAC and 
the ﬁrst exon shared in common by all the transcripts is located at the 
N-terminal border of the ﬁrst RPEL domain, we noted that amino acid 
sequences of this domain is identical in BSAC, FLMKL1 and MELODY, 
except for the very ﬁrst amino acid residue which is switched to ser- 
ine in BSAC instead of asparagine present in FLMKL1 and MELODY 
( Fig. 1 C). The nucleotide and amino acid sequences of rat MKL1 tran- 
scripts identiﬁed here are summarized in supporting information ﬁg- 
ures available online ( Figs. S1 , S2 and S3 ). In comparing these cDNA 
nucleotide sequences with the corresponding rat genomic sequence 
(NCBI Reference Sequence: NW 047780.1 and NW 001084859.1 ), we 
noted a discrepancy in one nucleotide (the 2816th base in FLMKL1 
(DDBJ: AB588919 ), the 2671st base in BSAC (DDBJ: AB588920 ) and 
the 2798th base in MELODY (DDBJ: AB588921 ) ( Figs. S1 , S2 and S3 ). 
All three cDNA sequences contain T residues rather than a C residue 
reported in the genomic database, a substitution that would result in 
a switch from serine to leucine. It is still unknown whether or not 
this conversion is due to RNA editing or a single nucleotide polymor- 
phism. 
3.2. Tissue-distribution of rat MKL1 transcripts 
We next examined the tissue-distribution of FLMKL1, BSAC, and 
MELODY mRNAs. Speciﬁc primers were designed for the detection of 
FLMKL1, BSAC and MELODY expression as shown in Fig. 1 A (arrows). 
Initially, we conﬁrmed whether quantitative PCR analysis could de- 
tect the mRNA expression of each transcript speciﬁcally. No PCR- 
ampliﬁcation was observed in the reverse transcription-free samples 
( Fig. S4 , control −), but bands appeared when each transcript-carrying 
plasmid template ( Fig. S4 , control + ) or reverse transcribed samples 
( Fig. S4 , 14 kinds of tissues) were used. This showed that PCR products 
Mitsuru Ishikawa et al. / FEBS Open Bio 3 (2013) 387–393 391 
Fig. 3. Differential expression of rat MKL1 transcripts in the developing brain . Samples were prepared from the olfactory bulb (A–C), cerebellum (D–F), hippocampus (G–I), 
cerebral cortex (J–L) and total brain (M–O) and subjected to real-time quantitative PCR analysis with FLMKL1 (A, D, G, J and M), BSAC (B, E, H, K and N) and MELODY (C, F, I, L and 
O) speciﬁc primers. E15, embryonic day 15; E18, embryonic day 18; P0, post-natal day 0 (day of birth); P5, post-natal day 5; P10, post-natal day 10; P15, post-natal day 15, P21; 
post-natal day 21. Bar graphs represent the means ± SD from at least three independent experiments. 
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Fig. 4. Effects of MKL1 isoforms on SRF- and CREB-mediated transcriptional responses 
in NIH3T3 cells . (A) The expression level of FLAG-tagged MKL1 variants. FLAG-tagged 
FLMKL1, BSAC, MELODY or MKL1met (the amount indicated as 0.50–1.00) was co- 
transfected with GFP vector (1 μg / well) into NIH3T3 cells. Twenty-four hours later, 
cell lysates were collected and Western blotting was performed. In transfection studies 
presented in this and subsequent ﬁgures, empty vector was added as needed to keep 
the total amount of expression vectors used for transfection per well constant. (B–D) 
Either 1.0 μg / well of empty vector (Empty), 0.1, 0.25, 0.5, 0.75 and 1.0 μg / well of FLAG- 
tagged FLMKL1, BSAC, MELODY or MKL1met was co-transfected with ﬁreﬂy luciferase 
vector (B: 3D.A.Luc, C: 5 × SRE-Luc, D: 4 × CRE-Luc, 1.0 μg / well) and Renilla luciferase 
reporter vectors, TK-Renilla (0.2 μg / well) into NIH3T3 cells. Twenty-four hours later, 
luciferase activities were measured. To keep the total amount of transfected vector 
constant (2 μg total / well), empty vector was added as needed. Bar graphs represent 
the means ± SD from at least three samples. * p < 0.05 (vs. empty), ** p < 0.01 (vs. 
empty), *** p < 0.001 (vs. empty), ## p < 0.01 (vs. FLMKL1). 
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sere derived from cDNA, but not from contamination with genomic 
NA. Furthermore, only one band was generated in each assay and 
t had the predicted size, suggesting that the quantitative PCR analy- 
is speciﬁcally detected only one ampliﬁed band of interest, but not 
on-speciﬁc bands. Two initiator codons of FLMKL1 give rise to two 
ranslation products, FLMKL1 and MKL1met. Therefore, the PCR prod- 
cts ampliﬁed with primers for FLMKL1 included both FLMKL1 and 
KL1met. Quantitative real-time PCR revealed that all MKL1 tran- 
cripts were enriched in the nervous system ( Fig. 2 ) and that the level 
f MELODY mRNA was very low compared to other transcripts ( Fig. 
 C). As expression of MELODY is orders of magnitude below that of 
LMKL1 and BSAC, its impact on cell signaling is unclear. The expres- 
ion of FLMKL1 and MELODY was relatively high in the testis and the olfactory bulb ( Fig. 2 A and C). BSAC was enriched in the hippocampus 
( Fig. 2 B). 
3.3. Developmental regulation of rat MKL1 transcripts in the brain 
As the tissue survey described above showed that MKL1 mRNA 
was highly expressed in the brain ( Fig. 2 ), we proceeded to determine 
the expression proﬁle of MKL1 transcripts during brain development. 
Using quantitative PCR analysis of cDNAs derived from several brain 
regions at different developmental stages, we found that BSAC was 
the most abundant of the three MKL1 transcripts during brain devel- 
opment ( Fig. 3 ). The expression level of BSAC mRNA increased after 
P10–P15 in both the hippocampus and the cerebral cortex ( Fig. 3 H and 
K). In contrast, MELODY mRNA level decreased during development 
in several brain regions ( Fig. 3 C, I, L and O). The expression pattern 
of FLMKL1 mRNA during development varied across different regions 
( Fig. 3 A, D, G, J and M). In combination, these data show that the pat- 
tern of expression of the alternative transcripts generated from the 
rat MKL1 gene is dynamically regulated during brain development. 
3.4. SRF coactivator function of rat MKL1 isoforms 
Next, we examined the functional activities of MKL1 isoforms in 
NIH3T3 cells. We ﬁrst checked the expression level of FLAG-tagged 
MKL1 isoforms. As shown in Fig. 4 A, the expression levels of MKL1 
isoforms were varied when 0.50–1.00 μg of FLAG-MKL1 expression 
vectors were transfected. Likewise, we also checked the effects of 
these four MKL1 isoforms on SRF-mediated transcriptional responses 
in NIH3T3 cells. All four MKL1 isoforms increased SRF-mediated tran- 
scriptional responses ( Fig. 4 B and C). When the same amounts of MKL1 
expression vector were transfected into NIH3T3 cells, MKL1met was 
the most effective in driving SRF-mediated transcription among the 
four MKL1 isoforms. On the other hand, all four MKL1 isoforms did 
not activate cAMP response element (CRE)-mediated transcription 
signiﬁcantly in NIH3T3 cells ( Fig. 4 D). 
4. Discussion 
In this study, we have identiﬁed three transcripts generated from 
the rat MKL1 gene: two of these, FLMKL1 and BSAC are homologous 
to mouse MKL1 transcripts, while the third, MELODY, represents a 
novel transcript ( Fig. 1 ). Analysis of the exon–intron structure of these 
transcripts demonstrated that each has a distinct 5 ′ -exon, implying 
that their transcription may be regulated separately by alternative 
promoters. Searching transcription factor-binding sites revealed that 
candidate binding sites of transcription factors located upstream of 
5 ′ -ends of rat MKL1 isoforms were different. This indicates that differ- 
ent transcription factors may be involved in the transcription of MKL1 
isoforms in a spatiotemporal manner. In fact, analysis of their expres- 
sion proﬁles revealed that all three MKL1 transcripts are enriched in 
the nervous system and display distinct spatiotemporal patterns of 
expression during brain development ( Figs. 2 and 3 ). In terms of ex- 
pression levels, there was a marked difference among the three MKL1 
transcripts; in particular, the expression of MELODY is substantially 
lower than the other two transcripts ( Figs. 2 and 3 ). Therefore, the in- 
ﬂuence of endogenous MELODY on SRF-mediated transcription under 
basal conditions may be negligible. 
The functional properties of rat MKL1 isoforms indicates that 
the novel MKL1 isoform, MELODY, in addition to rat FLMKL1, BSAC, 
MKL1met isoforms strongly enhanced SRF coactivation ( Fig. 4 B and 
C). Analysis of the domain structure of the proteins generated from 
these MKL1 transcripts indicate that FLMKL1, BSAC and MELODY have 
three G-actin-binding RPEL motifs, while MKL1met has two RPEL 
motifs ( Fig. 1 ). Comparison in every amount of MKL1 isoform vec- 
tors showed that MKL1met tends to be more active than other iso- 
forms. Three RPEL motifs in a single MKL1 molecule appear to bind 
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 to ﬁve G-actins [ 14 ]. Assuming that loss of one of these RPEL mo-
tifs decreases the stoichiometry and / or afﬁnity of the interaction of
MKL1 met with G-actin, may promote the nuclear localization, and
may cause stronger activity of SRF coactivator function. In this study,
we evaluated the effect of overexpressed MKL1 isoforms in NIH3T3
cells. Thus, further studies would be required for identiﬁcation and
function of endogenous MKL1met protein in a variety of cell types
and tissues. 
Although we have identiﬁed rat MKL1 isoforms, it is important
to note that additional MKL1 isoforms may remain to be identiﬁed.
Stern et al. [ 15 ] indicate that an MAL / MKL1 variant of relatively small
size (approximately 65 kDa) is expressed in neurons. Since the rat
MKL1 variants identiﬁed in this study are much larger, this smaller
variant may represent another rat MKL1 variant that remains to be
characterized. Further studies are needed to determine if this putative
∼65 kDa form is generated from a distinct transcript or via alternative
translation of one of the three transcripts described herein. 
Analysis of another SRF coactivator, myocardin, [ 16 ] has demon-
strated that alternative splicing gives rise to myocardin protein iso-
forms with different N-termini, a region that contains RPEL motifs
[ 17 ]. Notably, differences in this N-terminal region affect binding of
myocardin to myocyte enhancer factor 2 (MEF2), thereby regulating
MEF2-mediated transcription [ 17 ]. In a similar vein, it is conceivable
that the different N-termini found in MKL1 isoforms may also medi-
ate their differential interaction with other transcription factors. To
clarify the functional role of the distinct N-terminal regions of MKL1
isoforms, further studies aimed at searching for interacting proteins
or at examining isoform-speciﬁc knock down by RNA interference
may be valuable. 
In summary, we have identiﬁed a set of rat MKL1 transcripts that
are differentially expressed in developing and mature brain. Our pre-
vious study demonstrated that SRF-target β-actin gene promoter was
increased by overexpression of mouse MKL1 and MKL2 in primary
cultured cortical neurons [ 12 ]. To precisely investigate differential ef-
fects of MKL1 isoforms on endogenous SRF-target genes, the rescue
experiments with overexpression of MKL1 isoforms in the cells, de-
rived from MKL1 knock-out mice, might be needed. Taken together,
our ﬁndings suggest that expression of multiple MKL1 isoforms helps
to ﬁne tune changes in gene expression in both developing and ma-
ture brain. 
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